Neurocrine Bio. (NBIX) PT Lowered to $115 at Wells Fargo
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $155.64 -1.71%
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
Wells Fargo analyst Mohit Bansal lowered the price target on Neurocrine Bio. (NASDAQ: NBIX) to $115.00 (from $120.00) while maintaining a Equal Weight rating.
You May Also Be Interested In
- Neurocrine Bio. (NBIX) PT Raised to $253 at Citi
- The Campbell's Co. (CPB) PT Raised to $19 at UBS, Sell Rating Maintained
- Zscaler (ZS) PT Raised to $190 at FBN Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
